Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 37.52% vs 28.49% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 213.44% vs 149.83% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 94.74% vs 67.06% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 288.37% vs 310.76% in Mar 2024
Compare Profit and Loss Results of Aptus Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
24.00
302.00
-278.00
-92.05%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
24.00
302.00
-278.00
-92.05%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-7.00
4.00
57.14%
Raw Materials Consumed
12.00
164.00
-152.00
-92.68%
Power & Fuel Cost
0.00
8.00
-8.00
-100.00%
Employee Cost
3.00
61.00
-58.00
-95.08%
Operating Expenses
1.00
10.00
-9.00
-90.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
12.00
-9.00
-75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
19.00
272.00
-253.00
-93.01%
Operating Profit (PBDIT) excl Other Income
4.00
30.00
-26.00
-86.67%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
4.00
32.00
-28.00
-87.50%
Interest
0.00
17.00
-17.00
-100.00%
Profit before Depriciation and Tax
4.00
15.00
-11.00
-73.33%
Depreciation
0.00
9.00
-9.00
-100.00%
Profit Before Taxation & Exceptional Items
4.00
5.00
-1.00
-20.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
5.00
-1.00
-20.00%
Provision for Tax
1.00
-2.00
3.00
150.00%
Profit After Tax
3.00
7.00
-4.00
-57.14%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
42.00
-41.00
-97.62%
Profit Available for appropriations
4.00
50.00
-46.00
-92.00%
Appropriations
4.00
50.00
-46.00
-92.00%
Equity Dividend (%)
0%
12%
-12.00
Earnings Per Share
6.37
4.89
1.48
30.27%
Profit And Loss - Net Sales
Net Sales 24.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.52% vs 28.49% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 213.44% vs 149.83% in Mar 2024
Profit And Loss - Interest
Interest 0.47 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 94.74% vs 67.06% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 3.10 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 288.37% vs 310.76% in Mar 2024






